Predicting GLP-1 Discontinuation From Pharmacy Claims
Published: | Updated:
|Articles|December 1, 1996
Supplements and Featured Publications
- Creating an Optimal Strategy for Lipid Management
- Volume 2
- Issue 11 Suppl
Dialogue: Implementation of Guidelines in a Managed Care Setting
Advertisement
Articles in this issue
almost 30 years ago
Dialogue: The Lipid-Lowering Formularyalmost 30 years ago
Case Study Balmost 30 years ago
Case Study Calmost 30 years ago
Case Study Dalmost 30 years ago
Goals and Objectivesalmost 30 years ago
Introduction: Creating an Optimal Strategy for Lipid Managementalmost 30 years ago
Recent Clinical Trials and Aggressive Management of Dyslipidemic Patientsalmost 30 years ago
Epidemiologic Studies of Diet and Drug Therapy to Reach Target LDL-C Levelsalmost 30 years ago
Implementation of Guidelines in a Managed Care Settingalmost 30 years ago
The Lipid-Lowering FormularyAdvertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
MFN Drug Agreements Could Raise Prices Worldwide
2
Newer Agents, New Advantages: Brexpiprazole, Cariprazine, and Lumateperone in MDD
3
Dosing, Tolerability, and Formulary Impact: Aripiprazole and Quetiapine XR in MDD
4
FDA Clears First Alzheimer Blood Test for Adults as Young as 40
5